OmniAb, Inc. (OABI) Revenue Growth
OmniAb, Inc. (OABI) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2022-12-31 | N/A |
| 2023-12-31 | -42.17% |
| 2024-12-31 | -22.75% |
| 2025-12-31 | -29.27% |
How OABI compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| NBIX | Neurocrine Biosciences Inc. | 21.45% |
| INCY | Incyte Corporation | 21.22% |
| QTRX | Quanterix Corporation | 1.07% |
| AQST | Aquestive Therapeutics Inc. | -22.61% |
| EBS | Emergent BioSolutions Inc. | -28.81% |
These are five companies in the same sector as OABI with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get OmniAb, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("OABI", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | OABI | $4.33 | -8.84% | 1.70M |
| 3 | ||||
| 4 | ||||
| 5 |